Additional information
Off white Powder
212316-86-4
ACI-120721
[2-Butyl-1-[[2`-[1-[[2-butyl-4-chloro-1-[[2`-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl-4-chloro-1H-imidazol-5-yl]methanol potassium
[2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl-4-chloro-1H-imidazol-5-yl]methanol potassium (1H-dimer-USP)
231.1-231.6
C44H43Cl2KN12O
865.9
Ambient
2-8°C
N1-Losartanyl-losartan Potassium Salt; [2-Butyl-1-[[2'-[1-[[2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-yl]methyl]-1H-tetrazol-5-yl]biphenyl-4-yl]methyl]-4-chloro-1H-imidazol-5-yl]methanol Potassium Salt;
Angiotensin receptor blocker





![N-ETHYL AZILSARTAN MEDOXOMIL (25 mg) ((5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-{[2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-4-biphenylyl]methyl}-1H-benzimidazole-7-carboxylate)](https://analyticachemie.in/wp-content/uploads/uspimage-1.jpg)